MONDAY, Sept. 23, 2024 -- For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis...
Vous n'êtes pas connecté
WEDNESDAY, Sept. 25, 2024 -- For patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields improvement in quality of life and a reduction in flares, according to a study presented at the annual...
MONDAY, Sept. 23, 2024 -- For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis...
THURSDAY, Sept. 19, 2024 -- For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by...
WEDNESDAY, Sept. 25, 2024 -- For patients with type 2 diabetes (T2D) and opioid use disorder (OUD), semaglutide is associated with a significantly...
FRIDAY, Sept. 27, 2024 -- For patients with obesity, type 2 diabetes, and estimated glomerular filtration rate (eGFR) 20 to 60 mL/min/1.73 m2,...
MONDAY, Sept. 16, 2024 -- A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal...
MONDAY, Sept. 16, 2024 -- A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal...
TUESDAY, Sept. 17, 2024 -- The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with...
WEDNESDAY, Sept. 18, 2024 -- The corner bodega or neighborhood Kwik-E-Mart could be fueling childhood obesity in the United States, a new study...
MONDAY, Sept. 23, 2024 -- In a report issued by the American Society of Nephrology and published online Sept. 18 in the Journal of the American...
Studies reported at ESMO 2024 have revealed new groups of women with early-stage (1) and cervical cancers (2) who gain clinically meaningful benefit...